Company Overview and News

Chipmakers' Rout Widens After TSMC Ignites Smartphone Fears - Bloomberg

15m bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

Should Value Investors Care About Nvidia (NVDA)?

2018-03-26 zacks
Shares of Nvidia (NVDA - Free Report) moved higher in early morning trading Monday as tech investors look to rebound from the sector’s tough stretch of trading last week. Despite recent volatility, Nvidia is up about 21% over the past three months, underscoring the company’s position as a tech bellwether and proving that Wall Street is still infatuated with this red-hot growth stock.
Upvote Downvote

10 Triple-A Stocks for the Second Quarter | InvestorPlace

2018-03-23 investorplace
When the market drops 724 points in one day and the volatility index (aka the VIX) spikes up 30%, you know that we’re in a very different place.
Upvote Downvote

Most Connected Devices Are Easy to Hack. This Company Says It Can Fix That - Bloomberg

2018-03-14 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

How Nvidia (NVDA) Can Justify Its Stock's Sky-High Valuation

2018-03-09 zacks
Shares of Nvidia (NVDA - Free Report) gained about 1.5% on Friday, extending the red-hot stock’s impressive run and lifting its three-month gains to over 25%. The Wall Street darling remains a dominant player in the gaming industry, but its ongoing rise to the top of the technology sector comes on the back of tireless advancements in autonomous driving, machine learning, and artificial intelligence.
Upvote Downvote

STMicroelectronics Is An Inexpensive Stock - Cramer's Lightning Round (3/8/18)

2018-03-09 seekingalpha
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Thursday, March 8.
Upvote Downvote

Cramer's lightning round: I can't find a reason to buy Kraft Heinz

2018-03-08 cnbc
Kraft Heinz Co.: "I don't know, man. It's at a 52-week low, it yields 3.7 [percent], yet I still can't find a compelling reason to buy it. I like growth."
Upvote Downvote

Startup With Century-Old Technology Plots IPO, New Funding Round - Bloomberg

2018-02-28 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

Autonomous Driving Boom Spurs STMicro to Develop New Chips - Bloomberg

2018-02-27 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

Market Conflict Next Week: What To Watch

2018-02-19 seekingalpha
After a wild and volatile 2 weeks, what to think about for the short trading week to come.
Upvote Downvote

Cramer's lightning round: Take a long-term view on Johnson & Johnson

2018-01-31 cnbc
Johnson & Johnson: "JNJ's been nonstop down. It's actually down for the year. It's down 10 straight points. You know what I say? Buy, buy, buy, because this is one of the highest quality companies in the world. Take a longer term view. Buy some here and then buy some if it goes below."
Upvote Downvote

Intel (INTC) Looks Good: Stock Adds 10.6% in Session

2018-01-29 zacks
Intel Corporation (INTC - Free Report) was a big mover last session, as the company saw its shares rise nearly 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $42.50 to $46.85 in the past one-month time frame.
Upvote Downvote

Why Investors Should Retain IBM Stock in Their Portfolio

2018-01-26 zacks
Shares of IBM Corporation (IBM - Free Report) have been moving north backed by expanding product portfolio, strategic acquisitions, investor-friendly policies and encouraging fourth-quarter 2017 results.
Upvote Downvote

Alphabet Adds Cybersecurity Unit Chronicle to its Portfolio

2018-01-25 zacks
Alphabet Inc. (GOOGL - Free Report) recently announced a cybersecurity business unit called Chronicle. The new unit, under development for the past two years, has been spun out of the company's "X" research lab.
Upvote Downvote

STMicroelectronics' (STM) CEO Carlo Bozotti on Q4 and Full-Year 2017 Results - Earnings Call Transcript

2018-01-25 seekingalpha
STMicroelectronics NV (NYSE:STM) Q4 & Full-Year 2017 Earnings Conference Call January 25, 2017 3:30 AM ET
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...